semaj83/ctmatch_classification huggingface dataset:
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 16.0-999.0,  Hepatitis E Healthy people aged over 16 years old at the time of the first vaccination, normal intelligence and agree to sign the informed consent form Healthy subjects as established by medical history and history-oriented clinical examination before entering into the study Subjects will reside in the study region in the next 7 months Free of history of hepatitis E Can comply with the request of study Axillary temperature is below 37 degree centigrade  For dose 1 receiving other vaccine or immunoglobulin within two weeks Having serious allergic history to vaccine and medicine Eclampsia, epilepsy, encephalopathy and history of mental disease or family Thrombocytopenia or other disturbance of blood coagulation which would lead to muscle injection taboo Fixed or suspected deficiency of immunologic function, containing immunosuppressant treatment, genetic defect, HIV or other factors Congenital malformation, eccyliosis or severe chronic disease Fixed or suspected other disease including fever, active infection, liver and kidney disease, angiocardiopathy, malignancy, acute and chronic disease joining other clinical study undergoing women pregnant or in lactation. For dose 2 or 3
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Lactation Women between the ages of 18 and 45 years Good general health Lactating Singleton birth Two to twelve weeks postpartum Have a full term (>37 weeks gestation) healthy infant Is successfully fully breastfeeding at the time they enter the study Intend to fully breastfeed their infants for the following 4 weeks at the time of enrollment  Chronic illnesses (e.g. diabetes, hypertension, bronchial asthma, Gastroesophageal Reflux Disease (GERD), atopic dermatitis, celiac disease or gluten sensitivity, Crohn's Disease, ulcerative colitis, eating disorders, breast cancer, blood disorder, psychiatric) Pre-pregnant BMI (>50) History of alcohol, drug abuse or cigarette smoking Currently using the following pharmaceuticals: diuretics, pseudoephedrine, anticholinergics, and an estrogen-containing birth control pill or using an estrogen-containing device Currently consuming other drugs/herbals used to induce milk production including metoclopramide, domperidone, or other drugs/herbals (i.e. fenugreek capsules, goat's rue products, or "More Milk" capsules or tinctures) Sensitivity or known allergies to peanuts, soybeans, or chick peas Sensitivity or known allergies to plants in the Apiaceae/carrot plant family (e.g. anise, celery, coriander, fennel) or the compound anethole Sensitivity or known allergies to plants in the Asteraceae/daisy family (e.g. blessed thistle, echinacea, or calendula) Taking a selective serotonin reuptake inhibitor (SSRI)
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 75.0-999.0,  Influenza Immunization Older Adults Over Age 75 Adults over age 75 years  Allergies to egg or vaccine Active malignancies On radiation or chemotherapy Active systemic inflammatory diseases including rheumatoid arthritis, Crohn's disease, and ulcerative colitis Acute exacerbation of chronic cardiopulmonary conditions including decompensated CHF or COPD Taking oral steroids (such as prednisone) or immune modulating drugs (such as methotrexate) Lacking the capacity to consent (individuals who do not understand what Flu shot is or need someone else to decide if s/he should get the Flu shot)
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-999.0,  Endometriosis Female, 20 years of age and older 2. Weight between 40kg~70kg 3. Women who agreed using double contraception method and spermicide, avoiding breast-feeding for at least 30days after IP(investigational product) dosing 4. A history of regular menstrual cycles (cycle: 28±7day, duration: 2~7day) for at least 2 years and a positive ovulation test between day 11 and 21 in the preceding menstrual cycle of IP(investigational product) dosing  Women who are pregnant or serum/urine hCG(human chorionic gonadotropin) positive or breast-feeding 2. A history of breast cancer, genital cancer or any estrogen dependent tumor 3. Specified or unspecified diagnosed infertility or history of natural abortion over three times 4. A history of taking other Investigational product within 60days before screening visit or taking ETC drug(Ethical drugs), oriental medicine or OTC drugs(Over-the-Counter drugs) within 14days before screening visit 5. Clinically significant Gynecological disease identified by ultrasonography including estrogen dependent tumor or lesion, sever inflammation or synechia 6. AST(Aspartate aminotransferase), ALT(Alanine aminotransferase) ≥ 2.5 times the upper limit of normal 7. QTc > 450ms on electrocardiogram result
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Healthy Signed informed consent prior to any study-mandated procedure Japanese or Caucasian. (Japanese subjects: both parents of the subject are Japanese [born in Japan]. Caucasian subjects: both parents of the subject are Caucasian) Body mass index between 18 and 28 kg/m^2, inclusive Women not of childbearing potential Women of childbearing potential must have a negative serum pregnancy test at screening and a negative urine pregnancy test prior to drug intake on Day 1; use a reliable method of contraception and continue this contraception for the duration of the study and for at least 2 months after study drug intake. In addition, her partner must use a condom Systolic blood pressure 100-145 mmHg, diastolic blood pressure 50-90 mmHg, and heart rate (HR) 50-95 beats per minute (inclusive) lead electrocardiogram without clinically relevant abnormalities at screening Hematology and clinical chemistry results not deviating from the normal range to a clinically relevant extent at screening Negative results from urine drug screen at screening Ability to communicate well with the Investigator (if necessary with the help of an interpreter) and to understand and comply with the requirements of the study  Electrocardiograph PQ/PR interval (time interval from the beginning of the P wave to the beginning of the QRS complex) > 200 milliseconds at screening Nursing woman History of asthma or chronic obstructive pulmonary disease Known hypersensitivity to any excipients of the drug formulation Treatment with another investigational drug within 3 months prior to screening Excessive caffeine consumption, defined as > 800 mg per day at screening History or clinical evidence of any disease and/or existence of any surgical or medical condition that might interfere with the absorption, distribution, metabolism or excretion of the study drug Any cardiac condition or illness, including ECG abnormalities, with a potential to increase the cardiac risk of the subject Smoking within the last month prior to screening Any immunosuppressive treatment within 6 weeks before study drug administration
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Immediate Postpartum Hemorrhage The trial will women aged 18 years or older who have just had a vaginal delivery between 35 and 42 weeks of gestation with a PPH persisting 15 minutes after the injection of 5 UI or 10 IU of oxytocin by slow IV and uterine massage and who provided informed written consent. If her condition does not allow her consent to be obtained immediately in ethically acceptable conditions, it may be obtained from her healthcare agent, or if there is none, from a family member, if present. In case where neither a healthcare agent nor a family member is present on the day of the patient can nonetheless be included. She will be informed secondarily, and her consent will be requested for the potential continuation of the research and use of her data Patient beneficiary or affiliated to a health insurance  The trial will not women who have just had a cesarean delivery with a contraindication to Sulprostone with clinical chorioamnionitis or an in utero fetal death or a medically-indicated termination of pregnancy with PPH secondary to cervicovaginal lacerations without any uterine hemorrhage, uterine rupture, or placenta accreta with arterial bleeding requiring embolization with a purulent infection of the cervix, vagina or uterus with symptoms indicating a hysterectomy with cervical cancer
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-65.0,  Healthy Healthy males and females Aged between 20 and 65 years old BMI in the normal range (18.5 to 25.0 kg/m2) Having signed his/her consent form  Clinically relevant digestive (including malabsorption or major surgery), renal, hepatic, pancreatic or metabolic disease (diabetes, hypo or hyperthyroidism, hypo or hypercorticism), as determined by the medical (screening) visit and a standard blood chemistry analysis (glucose, total cholesterol, ALDL, AHDL, triglycerides, ASAT, ALTI, gamma GT, RCRP, creatinine) Medically diagnosed anemia based on a blood formula Food allergy, lactose intolerance and intolerance to milk proteins (anamnesis) Smokers (anamnesis) Pregnancy (anamnesis) Under corticoids or hormone (adrenal, thyroid) treatment Alcohol intake: > 2 units a day (anamnesis) Consumption of illicit drugs (anamnesis) Having given blood within the last month, or willing to make a blood donation until one month following the end of the study Subject who cannot be expected to comply with the study procedures, including consuming the test product
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-45.0,  Meal Timing Are 20-45 years of age Have a weight between 150 and 220 lbs Have a body mass index between 25 and 35 kg/m2 inclusive (a number calculated from your height and weight) If you are a female, have a regular menstrual cycle that is between 25 and 35 days long If you are female, had your period within the last 35 days Regularly go to sleep between 9:30 pm and 12:00 am Regularly eat dinner 9 or more hours after eating breakfast Are willing to have about 2/3 cup of your blood stored for future research related to this study  Have diabetes or are on anti-diabetes medication Suffer from significant cardiovascular, renal (kidney), cardiac (heart), liver, lung or nervous system disease Have stomach or intestinal problems Regularly use medications such as steroids, beta blockers, adrenergic-stimulating agents, and laxatives Take any medications or supplements known to affect sleep, circadian rhythms, or metabolism (with the exception that certain forms of birth control are allowed) Have abnormal lab work that is clinically significant in the opinion of the study physician Are pregnant or lactating Take the Depo Provera shot, or use an Interuterine Device (IUD) or hormone patch for birth control If you are on hormonal birth control, have been on a stable dose for less than 3 months Have smoked or used nicotine/tobacco products within the last 3 months
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.083-999.0,  Pulmonary Arterial Hypertension of Congenital Heart Disease The patient has a congenital heart disease other than patent foramen ovale The diagnosis of pulmonary hypertension was confirmed by cardiac catheterization. Only patients with Eisenmenger syndrome can be included without catheterization The catheterization was done after 1 January 2009 A mean pulmonary artery pressure > 25 mm Hg Pulmonary vascular resistances > 3 piece Wood m2 Pulmonary capillary pressure available Consent for in the study must be signed by parents or legal guardians for minors, by the patient for adults The patient he had a surgical procedure or interventional catheterization cardiac catheterization between his diagnosis and in the observatory? If yes, it can only be included if a new catheterization confirmed the persistence of HTAP at least 6 months after the procedure Patient follow-up (at least once a year) in the center for its HTAP associated with congenital heart disease its
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Recurrent Melanoma Stage IV Melanoma Signed written informed consent Histologically confirmed diagnosis of metastatic melanoma with the presence of the B-Raf proto-oncogene, serine/threonine kinase (BRAFV600) mutation Eastern Cooperative Oncology Group (ECOG) performance status < 3 Absolute neutrophil count (ANC) >= 1.0 x 10^9/L Hemoglobin (Hgb) >= 9 g/dL without transfusions Platelets (PLT) >= 90 x 10^9/L without transfusions Aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) =< 2.5 x upper limit of normal (ULN); patient with liver metastases =< 5 x ULN Total bilirubin =< 2 x ULN, or < 5 ULN if Gilbertâ€™s disease Creatinine =< 1.5 mg/dL, or calculated creatinine clearance (determined as per Cockcroft-Gault) >= 50 mL/min Left ventricular ejection fraction (LVEF) >= 50% as determined by a multigated acquisition (MUGA) scan or echocardiogram (ECHO)  Prior exposure to BRAF or MEK inhibitors Any active central nervous system (CNS) lesion (i.e., those with radiographically unstable, symptomatic lesions) and/or leptomeningeal metastases; however, patient treated with stereotactic radiotherapy, whole brain radiation or surgery are eligible if patient remained without evidence of CNS disease progression >= 4 weeks; patients must be off corticosteroid therapy for >= 2 weeks History or current evidence of retinal vein occlusion (RVO) or predisposing factors to RVO (e.g. uncontrolled glaucoma or ocular hypertension, history of hyperviscosity or hypercoagulability syndromes) History of retinal degenerative disease History of Gilbertâ€™s syndrome Previous or concurrent malignancy is not an provided that the other malignancy is considered under control and target lesions from melanoma are clearly defined for response assessment Impaired cardiovascular function or clinically significant cardiovascular diseases, including any of the following History of acute coronary syndromes (including myocardial infarction, unstable angina, coronary artery bypass grafting, coronary angioplasty, or stenting) < 6 months prior to screening Symptomatic chronic heart failure, history or current evidence of clinically significant cardiac arrhythmia and/or conduction abnormality < 6 months prior to screening except atrial fibrillation and paroxysmal supraventricular tachycardia Uncontrolled arterial hypertension despite medical treatment
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Food Selection healthy non-smoking BMI of 18-27 non-dieting typically consumes breakfast/lunch  distaste for eggs vegetarian current smoker restrained eating habits recent weight change history of significant disease of past medical history pregnant lactating irregular menstrual cycle
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-0.019,  Healthy  Healthy newborn infant Full term infant (= 37 weeks gestation; = 42 weeks gestation) Birth weight = 2500 g and < 4200 g Singleton birth Infant is = 7 days of age at the time of enrollment For the BF group: The infant's mother has elected to exclusively breastfeed her baby, from enrollment to 4 months of age For the FF groups: The infant's mother has elected to exclusively formula feed her baby, from enrollment to 4 months of age Having obtained his/her or his/her legal representative's consent  Newborn whose mother's BMI was normal (<20 or = 25) at start of pregnancy Newborn whose mother had developed gestational diabetes during pregnancy Newborn whose mother has diabetes of type-1 or type-2 Newborn whose mother smoked > 5 cigarettes / day during pregnancy Newborn whose mother had a drug dependence during pregnancy Newborn whose mother has a chronic infectious disease Newborn whose parents / caregivers cannot be expected to comply with treatment Newborn currently participating in another clinical trial